ArticleScientific reports2026
Acceptability of remotely supervised Home-Based transcranial direct current stimulation combined with Cognitive-behavioural-based app for peripartum depression: perspectives from women with lived experience and mental health professionals.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Peripartum depression (PPD) has a global prevalence of 20% significantly impacting societies. Yet, existing treatments face barriers for its uptake. This study examined the acceptability of a remotely supervised home-based transcranial direct current stimulation (tDCS) solution combined with a CBT-based app (the FLOW Neuroscience solution) for PPD, among women (experts by experience; EEs) and healthcare professionals (HPs). Fifteen EEs and 14 HPs participated in focus groups informed by the Theoretical Framework of Acceptability. Narratives were iteratively refined, using the template analysis method. Participants were overall positive about the treatment considering it supports patients' autonomy, freedom of choice and a universally accessible perinatal mental health care system. However, they also highlighted several concerns, such as the limitations of exclusively remote/virtual and bot-lead interventions which, on the one hand, may address fear of stigma about perinatal mental health, but on the other may also increase loneliness in depressed patients. Additionally, participants emphasized the need for effective communication strategies to build trust over health innovation and recommended the integration of home-based remotely supervised tDCS treatments combined with a CBT-based app into existing care models. Our findings suggest that while the FLOW solution addresses existing gaps in PPD it also presents some limitations. Here we provide user-centered actionable insights into the adjustment of this innovative, home-based solution to enhance access and engagement in PPD care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.